HAL anticorps (N-Term)
Aperçu rapide pour HAL anticorps (N-Term) (ABIN630816)
Antigène
Voir toutes HAL AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Specificité
- HAL antibody was raised against the N terminal of HAL
-
Purification
- Affinity purified
-
Immunogène
- HAL antibody was raised using the N terminal of HAL corresponding to a region with amino acids INKLQELQVNLVRSHSSGVGKPLSPERCRMLLALRINVLAKGYSGISLET
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
HAL Blocking Peptide, (ABIN939461), is also available for use as a blocking control in assays to test for specificity of this HAL antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of HAL antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- HAL (Histidine Ammonia-Lyase (HAL))
-
Autre désignation
- HAL
-
Sujet
- HAL is a cytosolic enzyme catalyzing the first reaction in histidine catabolism, the nonoxidative deamination of L-histidine to trans-urocanic acid. HAL defects cause histidinemia which is characterized by increased histidine and histamine and decreased urocanic acid in body fluids.
-
Poids moléculaire
- 72 kDa (MW of target protein)
Antigène
-